Coal tar

Generic Medicine Info
Indications and Dosage
Subacute and chronic psoriasis
Adult: As 0.5%, 2% gel: Apply onto affected ares(s) 1-4 times daily. As 5% emulsion: Apply thinly onto affected area(s) bid-tid. As 6 % cream; 2.3% soln: Apply onto affected area(s) once or twice daily. As 2% oint/aerosol foam; 0.5%, 1.5% lotion: Apply thinly onto affected area(s) 1-4 times daily.
Child: Same as adult dose.
Elderly: Same as adult dose.

Dandruff, Seborrhoeic dermatitis
Adult: As 1%, 2.5% shampoo: Massage into we scalp. Leave for several minutes then rinse thoroughly. May use up to twice weekly.
Child: Same as adult dose.
Elderly: Same as adult dose.

Psoriasis of skin and scalp
Adult: As a 5% emulsion: Apply a thin layer 2-3 times daily to affected areas, massage gently and leave to dry.
Child: >12 years Same as adult dose.
Elderly: Same as adult dose.
Application to inflamed or broken skin.
Special Precautions
Use with caution on the face, near eyes and mucous membranes. Do not apply to genital or rectal areas. Avoid use in patient with exacerbation of psoriasis. Avoid exposure to direct sunlight and sunlamps for at least 24-72 hr after application. May stain clothes and hair. If undergoing Goeckerman treatment, all coal tar preparation should be removed from skin before exposure to radiation. Pregnancy and lactation.
Adverse Reactions
Skin irritation and acne-like skin eruptions. Photosensitivity.
Description: Coal tar has antipruritic, keratoplastic and keratolytic properties. It slows down excessive epidermal cell turnover and is often used topically either alone or in combination with other drugs (e.g. salicyclic acid, sulfur) in conditions such as dandruff, seborrheic dermatitis or psoriasis.
Store below 25°C.
MIMS Class
Psoriasis, Seborrhea & Ichthyosis Preparations
Disclaimer: This information is independently developed by MIMS based on Coal tar from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in